Oliveda's growth faces long-term risks with reliance on consultants and unclear economics. Read more on why its 7x revenue ...

Fintel reports that on July 10, 2025, Macquarie downgraded their outlook for Core Scientific, Inc. - Equity Right ...

In a couple of weeks we will get the first reading for third quarter GDP growth, and the current consensus among economists ...